Pharmaceutical & Healthcare Annual Deals Analysis 2012

GlobalData
February 29, 2012
119 Pages - SKU: GBDT3806262
  • Executive Summary
  • Pharmaceutical & Healthcare, Global, Deals Summary
    • Pharmaceutical & Healthcare, Global, Deals Analysis, 2011
      • (Table) Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2007- 2011
      • (Table) Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Deals Analysis, 2011 by Quarter
        • (Table) Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
    • Pharmaceuticals & Healthcare, Global, by Type, Number of Deals and Deal Values, 2011
      • (Table) Figure 3: Pharmaceuticals & Healthcare, Global, Number Of Deals (%) and Deal Values (%), 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2011
    • Pharmaceuticals & Healthcare, Global, Top Deals, 2011
      • (Table) Pharmaceuticals & Healthcare, Top Deals, Global, 2011
    • Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2011
      • Medco Health Receives Shareholders' Approval For Its Acquisition By Express Scripts
      • Takeda Pharmaceutical Completes Acquisition Of Nycomed International For $13.7 Billion
      • Gilead Sciences Completes Acquisition Of Pharmasset For $11.2 Billion
      • Sanofi Completes Public Offering Of Notes For $7 Billion
      • Teva Completes Acquisition Of Cephalon For $6.8 Billion
      • DuPont Completes Acquisition Of Danisco
      • Amgen Completes Public Offering Of Senior Notes For $6 Billion
      • HCA Completes Public Offering Of Senior Secured Notes For $5 Billion
      • Teva Pharmaceutical Completes Public Offering Of Senior Notes For $5 Billion
      • Johnson & Johnson Completes Public Offering Of Notes For $4.4 Billion
  • Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2011
    • (Table) Pharmaceuticals & Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$ m), 2011
  • Pharmaceuticals & Healthcare, Global, Deal Summary, by Type
    • Pharmaceuticals & Healthcare, Global, M&A, 2011
      • (Table) Figure 4 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, M&A, 2011 by Quarter
        • (Table) Figure 5 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Top M&A Deals in 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2011
      • Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2011
        • (Table) Figure 6: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
    • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2011
      • (Table) Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2011 by Quarter
        • (Table) Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Pharmaceuticals & Healthcare, Global, IPO Deals, 2011
        • (Table) Figure 9: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top IPOs, 2011
      • Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2011
        • (Table) Figure 10: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2011
      • Pharmaceuticals & Healthcare, Global, PIPE Deals, 2011
        • (Table) Figure 11: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2011
      • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2011
        • (Table) Figure 12: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
    • Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2011
      • (Table) Figure 13: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global Debt Offerings, 2011 by Quarter
        • (Table) Figure 14: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2011
        • (Table) Figure 15: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2011
      • Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2011
        • (Table) Figure 16: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2011
      • Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2011
        • (Table) Figure 17: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2011
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, 2011
      • (Table) Figure 18: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, 2011 by Quarter
        • (Table) Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2011
        • (Table) Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2011
        • (Table) Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals and Deal Value (US$ m), 2011
        • (Table) Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2011
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2011
    • Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2011
      • (Table) Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2011 by Quarter
        • (Table) Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2011
        • (Table) Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2011
        • (Table) Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, Number Of Deals and Deal Value (US$ m), 2011
        • (Table) Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, 2011
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2011
        • (Table) Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2011
    • Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2011
      • (Table) Figure 33: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2011 by Quarter
        • (Table) Figure 34: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Top Private Equity Deals in 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2011
      • Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2011
        • (Table) Figure 35: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
    • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2011
      • (Table) Figure 36: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2011 by Quarter
        • (Table) Figure 37: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2011
        • (Table) Figure 38: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%) and Deal Values (%), 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2011
      • Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2011
        • (Table) Figure 39: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
      • Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year
        • (Table) Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2011
      • Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2011
        • (Table) Figure 40: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2011
        • (Table) Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2011
      • Top Venture Financing Deals in 2011
        • (Table) Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2011
  • Pharmaceuticals & Healthcare, Global, Deal Summary, By Market
    • Pharmaceuticals & Healthcare, Global, Oncology Deals, 2011
      • (Table) Figure 41: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Oncology Deals, 2011 by Quarter
        • (Table) Figure 42: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Oncology - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2011
      • (Table) Figure 43: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2011, 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2011 by Quarter
        • (Table) Figure 44: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Central Nervous System - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2011
      • (Table) Figure 45: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2011 by Quarter
        • (Table) Figure 46: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Infectious Disease - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Immunology Deals, 2011
      • (Table) Figure 47: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Immunology Deals, 2011 by Quarter
        • (Table) Figure 48: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Immunology - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2011
      • (Table) Figure 49: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2011 by Quarter
        • (Table) Figure 50: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Cardiovascular - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2011
      • (Table) Figure 51: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2011 by Quarter
        • (Table) Figure 52: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Metabolic Disorders - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2011
      • (Table) Figure 53: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2011 by Quarter
        • (Table) Figure 54: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
      • Gastrointestinal - Deals of the Year
  • Pharmaceuticals & Healthcare, Deal Summary, By Geography
    • Pharmaceuticals & Healthcare, North America Region, Deals, 2011
      • (Table) Figure 55: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, North America Region, Deals, 2011 by Quarter
        • (Table) Figure 56: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
      • North America - Deals of the Year
    • Pharmaceuticals & Healthcare, European Region Deals, 2011
      • (Table) Figure 57: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Europe, Deals, 2011 by Quarter
        • (Table) Figure 58: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
      • Europe - Deals of the Year
    • Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2011
      • (Table) Figure 59: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2011 by Quarter
        • (Table) Figure 60: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
      • Asia-Pacific - Deals of the Year
    • Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2011
      • (Table) Figure 61: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • (Table) Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
      • Pharmaceuticals & Healthcare, Rest of the World Deals, 2011 by Quarter
        • (Table) Figure 62: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
        • (Table) Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
      • Rest of the World - Deals of the Year
  • Pharmaceuticals & Healthcare, Global, Top Financial Advisors
    • Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2011
      • (Table) Figure 63: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2011
      • (Table) Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2011
    • Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2011
      • (Table) Figure 64: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2011
      • (Table) Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2011
  • Further Information
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclosure information
    • Disclaimer
 

SELECT A LICENSE

    Online Download  USD 3,500  
    Global Site License  USD 10,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!